Yield10 Bioscience, Inc. (YTEN) Tops Q4 EPS by 1c

Yield10 Bioscience, Inc. (NASDAQ: YTEN) reported Q4 EPS of ($0.19), $0.01 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $135 thousand versus the consensus estimate of $310 thousand.

For earnings history and earnings-related data on Yield10 Bioscience, Inc. (YTEN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c